The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hematopoietic stem cell transplantation (HSCT) compared to consolidation chemotherapy (CT) to increase leukemia free survival (LFS) in acute myelogenous leukemia (AML) patients between 60 and 75 years irrespective of genetic risk: Report from the AML 2004 of the East German Study Group (OSHO).
 
Dietger Niederwieser
Speakers' Bureau - Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Haifa Kathrin Al-Ali
Speakers' Bureau - Celgene; Novartis
Research Funding - Novartis (Inst)
 
Rainer Krahl
No Relationships to Disclose
 
Christoph Kahl
Travel, Accommodations, Expenses - Celgene; Medac; Teva
 
Hans-Heinrich Wolf
No Relationships to Disclose
 
Ute Kreibich
No Relationships to Disclose
 
Vladan Vucinic
No Relationships to Disclose
 
Ute Hegenbart
Honoraria - Janssen-Ortho
Travel, Accommodations, Expenses - Janssen
 
Carsten Hirt
No Relationships to Disclose
 
Norma Peter
No Relationships to Disclose
 
Bernhard Opitz
No Relationships to Disclose
 
Axel Florschütz
No Relationships to Disclose
 
Antje Schulze
No Relationships to Disclose
 
Sebastian Scholl
No Relationships to Disclose
 
Christian Jakob
Consulting or Advisory Role - Amgen; Celgene; Janssen-Ortho; Novartis
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen-Ortho; Novartis
 
Christian Junghanss
No Relationships to Disclose
 
Herbert Sayer
No Relationships to Disclose
 
Andreas Hochhaus
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - ARIAD (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
 
Thomas Fischer
No Relationships to Disclose
 
Georg Maschmeyer
No Relationships to Disclose